Eddie Dowling

Eddie Dowling currently serves as the Oncology Regional Sales Director - East at Verastem Oncology since February 2025. Previously, Eddie held the position of Executive Director, Radiotherapy Alliances and Operations at Cellectar Biosciences, Inc., overseeing the launch of iopofosine I-131 for Waldenstrom macroglobulinemia. At Bristol Myers Squibb, Eddie progressed through several roles including Sr. Director of US Cell Therapy Site Strategy and Field Operations, where strategic planning and operational execution for the Cell Therapy portfolio were key responsibilities. Earlier experience includes leadership roles at Merck and Novartis Pharmaceuticals, focusing on sales performance in Oncology, Virology, and various therapeutic areas. Eddie holds a BS in Sport and Entertainment Management from the University of South Carolina and a Certificate in Executive and Professional Coaching from The University of Texas at Dallas.